More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression

被引:36
|
作者
Lyons, Taylor [1 ]
Carhart-Harris, Robin Lester [1 ]
机构
[1] Imperial Coll London, Dept Med, Psychedel Res Grp, London, England
来源
FRONTIERS IN PSYCHOLOGY | 2018年 / 9卷
关键词
treatment-resistant depression; psilocybin; cognitive bias; pessimism; forecasting; LYSERGIC-ACID DIETHYLAMIDE; DEFAULT-MODE NETWORK; MYSTICAL-TYPE EXPERIENCES; 5-HT2A RECEPTOR-BINDING; DYSFUNCTIONAL ATTITUDES; SPIRITUAL SIGNIFICANCE; UNREALISTIC OPTIMISM; POSITIVE ILLUSIONS; THREATENING CANCER; HEALTHY-SUBJECTS;
D O I
10.3389/fpsyg.2018.01721
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: Evidence suggests that classical psychedelics can promote enduring changes in personality, attitudes and optimism, as well as improvements in mental health outcomes. Aim: To investigate the effects of a composite intervention, involving psilocybin, on pessimism biases in patients with treatment-resistant depression (TRD). Methods: Patients with TRD (n = 15) and matched, untreated non-depressed controls (n = 15) performed the Prediction Of Future Life Events (POFLE) task. The POFLE task requires participants to predict the likelihood of certain life events occurring within a 30day period, after which the actual rate of event occurrence is reported; this gives an index of potential pessimism versus optimism bias. Psilocybin was administered in two oral dosing sessions (10 and 25 mg) one week apart. Main outcome measures were collected at baseline and one week after the second dosing session. Results: Patients showed a significant pessimism bias at baseline [t(14) = 3.260, p = 0.006; 95% CI (-0.16, -0.03), g = 1.1] which was related to the severity of their depressive symptoms (r(s) = 0.55, p = 0.017). One week after psilocybin treatment, this bias was significantly decreased [t(14) = 2.714, p = 0.017; 95% CI (-0.21, -0.02), g = 0.7] and depressive symptoms were greatly improved [t(14) = 7.900, p < 0.001; 95% CI (16.17, 28.23), g = 1.9]; moreover, the magnitude of change in both variables was significantly correlated (r = -0.57, p = 0.014). Importantly, post treatment, patients became significantly more accurate at predicting the occurrence of future life events [t(14) = 1.857, p = 0.042; 95% CI (-0.01, 0.12), g = 0.6] whereas no such change was observed in the control subjects. Conclusion: These findings suggest that psilocybin with psychological support might correct pessimism biases in TRD, enabling a more positive and accurate outlook.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Psilocybin in Treatment-Resistant Depression
    Madras, Bertha K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (18): : 1708 - 1709
  • [2] Psilocybin for Treatment-Resistant Depression
    Lengvenyte, Aiste
    Olie, Emilie
    Courtet, Philippe
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (08):
  • [3] Psilocybin for Treatment-Resistant Depression Reply
    Goodwin, Guy M.
    Hellerstein, David J.
    Young, Allan H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (08):
  • [4] The use of psilocybin for treatment-resistant depression
    Johannesdottir, Arny
    Sigurdsson, Engilbert
    LAEKNABLADID, 2022, 108 (09): : 403 - 410
  • [5] Altered states: psilocybin for treatment-resistant depression
    Cowen, Phil
    LANCET PSYCHIATRY, 2016, 3 (07): : 592 - 593
  • [6] PSILOCYBIN-ASSISTED PSYCHOTHERAPY FOR TREATMENT-RESISTANT DEPRESSION
    Bright, S.
    Skeffington, P.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (01): : 22 - 23
  • [7] The development of psilocybin therapy for treatment-resistant depression: an update
    Borissova, Anya
    Rucker, James J.
    BJPSYCH BULLETIN, 2024, 48 (01): : 38 - 44
  • [8] The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression
    Goodwin, Guy M.
    Aaronson, Scott T.
    Alvarez, Oscar
    Carhart-Harris, Robin
    Chai-Rees, Jamie
    Croal, Megan
    Debattista, Charles
    Dunlop, Boadie W.
    Feifel, David
    Hellerstein, David J.
    Husain, Muhammad I.
    Kelly, John R.
    Kirlic, Namik
    Licht, Rasmus W.
    Marwood, Lindsey
    Meyer, Thomas D.
    Mistry, Sunil
    Nowakowska, Ania
    Palenicek, Tomas
    Repantis, Dimitris
    Schoevers, Robert A.
    Simmons, Hollie
    Somers, Metten
    Teoh, Emma
    Tsai, Joyce
    Wahba, Mourad
    Williams, Sam
    Young, Allan H.
    Young, Matthew B.
    Zisook, Sidney
    Malievskaia, Ekaterina
    JOURNAL OF AFFECTIVE DISORDERS, 2025, 372 : 523 - 532
  • [9] Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
    Roseman, Leor
    Demetriou, Lysia
    Wall, Matthew B.
    Nutt, David J.
    Carhart-Harris, Robin L.
    NEUROPHARMACOLOGY, 2018, 142 : 263 - 269
  • [10] Patients' Accounts of Increased "Connectedness" and "Acceptance" After Psilocybin for Treatment-Resistant Depression
    Watts, Rosalind
    Day, Camilla
    Krzanowski, Jacob
    Nutt, David
    Carhart-Harris, Robin
    JOURNAL OF HUMANISTIC PSYCHOLOGY, 2017, 57 (05) : 520 - 564